Fig. 2From: Monthly tegafur–uracil maintenance for increasing relapse-free survival in ypStage III rectal cancer patients after preoperative radiotherapy, radical resection, and 12 postoperative chemotherapy cycles: a retrospective studyKaplan–Meier 5-year cancer-specific survival curve of ypStage III rectal cancer patients. Patients were stratified according to maintenance therapy with monthly tegafur–uracil (with vs. without)Back to article page